SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses - ScienceDirect
Neuer Omikron-Subtyp auf dem Vormarsch | Max Delbrück Center
Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study - The
An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies | Nature Medicine
Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles | PNAS
Omicron variant of SARS‐CoV‐2: Genomics, transmissibility, and responses to current COVID‐19 vaccines - Araf - 2022 - Journal of Medical Virology - Wiley Online Library
Omikron PCR Test zur Bestimmung von der Omikron Variante
Omikron: Italien drängt zu europaweiten Beschränkungen
Omikron ist das Schreckgespenst - doch die Mutante kann die Pandemie beenden - FOCUS online
RKI - Coronavirus SARS-CoV-2 - Hilfestellung zur Ableitung variantenspezifischer PCR-Testungen aus charakteristischen Aminosäure-Austauschen und Deletionen bei SARS-CoV-2
Omikron: Italien drängt zu europaweiten Beschränkungen
Omicron: How do I know if I have it? - BBC News
SARS-CoV-2-Variante Omikron – Wikipedia
Corona: Wie gefährlich ist die Omikron-Variante? - quarks.de
Deutsches Primatenzentrum: Emerging Omicron subvariants BA.2.12.1, BA.4 and BA.5 are inhibited less efficiently by antibodies
Siemens Healthineers SARS-CoV-2 Testing Portfolio Detects Omicron Variant
Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa | Nature Medicine
How Ominous Is the Omicron Variant (B.1.1.529)?
Omicron (BA.2) variant | Expression vectors | InvivoGen
Omicron is a Multiply Recombinant Set of Variants That Have Evolved Over Many Months - SARS-CoV-2 Molecular Evolution - Virological
Omicron and Delta variant of SARS‐CoV‐2: A comparative computational study of spike protein - Kumar - 2022 - Journal of Medical Virology - Wiley Online Library
Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2 | Nature Communications
